Autolus Therapeutics (AUTL) Change in Cash (2018 - 2025)

Autolus Therapeutics (AUTL) has 8 years of Change in Cash data on file, last reported at $18.0 million in Q4 2025.

• Quarterly Change in Cash rose 104.19% year-over-year to $18.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$123.2 million (down 968.26% YoY) and the FY2025 annual result came in at -$123.2 million, down 968.26% from the prior year.
• Change in Cash grew to $18.0 million in Q4 2025, from -$37.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $519.2 million in Q1 2024 to a low of -$429.7 million in Q4 2024.
• A 5-year average of -$2.4 million and a median of -$38.6 million in 2023 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 1417.59% in 2024, down 2502.23% in 2024.
• Tracing AUTL's Change in Cash over 5 years: stood at $137.4 million in 2021, then jumped by 59.67% to $219.4 million in 2022, then plunged by 107.53% to -$16.5 million in 2023, then slumped by 2502.23% to -$429.7 million in 2024, then jumped by 104.19% to $18.0 million in 2025.
• The last three Change in Cash figures came in at $18.0 million (Q4 2025), -$37.7 million (Q3 2025), and $28.1 million (Q2 2025), per Business Quant data.